Mustang Bio Inc (MBIO)
0.3501
-0.01
(-2.67%)
USD |
NASDAQ |
Apr 24, 16:00
0.3407
-0.01
(-2.68%)
After-Hours: 20:00
Mustang Bio Cash from Operations (TTM): -49.48M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -49.48M |
September 30, 2023 | -57.51M |
June 30, 2023 | -61.40M |
March 31, 2023 | -66.58M |
December 31, 2022 | -65.07M |
September 30, 2022 | -64.48M |
June 30, 2022 | -59.86M |
March 31, 2022 | -54.38M |
December 31, 2021 | -53.67M |
September 30, 2021 | -48.44M |
June 30, 2021 | -47.27M |
March 31, 2021 | -42.75M |
December 31, 2020 | -37.32M |
September 30, 2020 | -37.33M |
June 30, 2020 | -36.04M |
Date | Value |
---|---|
March 31, 2020 | -37.25M |
December 31, 2019 | -33.58M |
September 30, 2019 | -30.61M |
June 30, 2019 | -25.58M |
March 31, 2019 | -20.16M |
December 31, 2018 | -19.24M |
September 30, 2018 | -17.89M |
June 30, 2018 | -18.86M |
March 31, 2018 | -16.48M |
December 31, 2017 | -12.95M |
September 30, 2017 | -10.04M |
June 30, 2017 | -5.838M |
March 31, 2017 | -5.584M |
December 31, 2016 | -4.129M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-66.58M
Minimum
Mar 2023
-25.58M
Maximum
Jun 2019
-47.82M
Average
-48.44M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Avinger Inc | -14.43M |
Fortress Biotech Inc | -128.22M |
AIM ImmunoTech Inc | -21.27M |
Protalix BioTherapeutics Inc | -1.318M |
Armata Pharmaceuticals Inc | -47.42M |